About 2.5 Million people worldwide have multiple sclerosis, a chronic central nervous system disease that can cause blurred vision, poor coordination, slurred speech, numbness and paralysis, among other things.
Despite the serious symptoms, diagnosis is often tricky because symptoms vary and can be hard for physicians to interpret. Gaithersburg, Maryland company DioGenix Inc. started up in 2008 to commercialize work on a lab test that could improve the diagnostic process.
A 150-patient clinical trial has just begun enrolling, the trial will validate its test, MS Precise, for early identification and diagnosis of multiple sclerosis.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3515